Legend Capital and Industrial Bank have supplied $70.5m in series B funding for Gambol Pet Group, a pet food manufacturer with operations in Asia, the US and Europe.

Jackson Laboratory cancer drug spinout Cyteir Therapeutics extended its series B round thanks to investors including Osage University Partners and Novo Holdings.

Atomico has led $56m series B round for Cambridge-allied rare disease therapy developer Healx, which also welcomed Intel Capital as a new shareholder.

BASF Venture Capital formed part of a consortium co-led by Pontifax Agtech and Temasek that supplied $85m in funding for pesticide developer Provivi.

Lilly Asia Ventures returned for the respiratory disease drug developer's series B round, having co-led its $85m series A last year.

Emergency response support platform RapidSOS added $25m to close a series B round that already featured CSAA and Microsoft's M12 unit.

Novo Holdings co-led a series C round for orthodontic brace technology developer Swift Health Systems, which has now raised more than $70m.

Morgan Stanley Private Equity backed a $42.2m round for non-banking lender Kogta Financial, having previously taken part in a November 2018 round through its Asia fund.

The scooter rental platform has now raised more than $95m altogether, after Axa Germany participated in a series B round that will fund European growth.

LG Technology Ventures and existing investors Novo, SR One and Takeda Ventures all took part in a round that will support the advance of Arcellx's immuno-oncology cell therapies.